Korro Bio (KRRO) News Today $17.67 -3.26 (-15.58%) Closing price 04:00 PM EasternExtended Trading$18.00 +0.32 (+1.84%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Schonfeld Strategic Advisors LLC Has $4.30 Million Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO)Schonfeld Strategic Advisors LLC trimmed its holdings in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 20.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 113,065 shares of the company's stock afterMay 5 at 5:11 AM | marketbeat.comAlly Bridge Group NY LLC Makes New Investment in Korro Bio, Inc. (NASDAQ:KRRO)Ally Bridge Group NY LLC acquired a new stake in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 70,678 shares of the company's stock, valued at apprMay 4 at 7:45 AM | marketbeat.comMarshall Wace LLP Purchases New Position in Korro Bio, Inc. (NASDAQ:KRRO)Marshall Wace LLP acquired a new position in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 18,461 shares of the company's stock, valued at approximately $703May 4 at 3:44 AM | marketbeat.comCantor Fitzgerald Predicts Korro Bio FY2025 EarningsKorro Bio, Inc. (NASDAQ:KRRO - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Korro Bio in a research report issued on Tuesday, April 29th. Cantor Fitzgerald analyst S. Seedhouse anticipates that the company will post earnings per share ofMay 3 at 8:12 AM | marketbeat.comKorro Bio (NASDAQ:KRRO) Upgraded at Cantor FitzgeraldCantor Fitzgerald upgraded Korro Bio to a "strong-buy" rating in a report on Tuesday.May 2 at 7:50 AM | marketbeat.comCantor Fitzgerald Weighs in on Korro Bio FY2025 EarningsMay 2 at 2:41 AM | americanbankingnews.comKorro Bio (NASDAQ:KRRO) Upgraded to "Strong-Buy" at Cantor FitzgeraldMay 1, 2025 | americanbankingnews.comCantor Fitzgerald Initiates Coverage of Korro Bio (KRRO) with Overweight RecommendationApril 30, 2025 | msn.comTri Locum Partners LP Acquires 80,202 Shares of Korro Bio, Inc. (NASDAQ:KRRO)Tri Locum Partners LP grew its stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 125.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 144,216 shares of the company's stock after acquiring an addApril 29, 2025 | marketbeat.comWalleye Capital LLC Takes Position in Korro Bio, Inc. (NASDAQ:KRRO)Walleye Capital LLC bought a new position in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 41,228 shares of the company's stock, valued at approximaApril 22, 2025 | marketbeat.comKorro Bio (NASDAQ:KRRO) Coverage Initiated at Chardan CapitalChardan Capital began coverage on shares of Korro Bio in a research note on Wednesday. They set a "buy" rating and a $25.00 target price for the company.April 18, 2025 | marketbeat.comChardan Capital Initiates a Buy Rating on Korro Bio (KRRO)April 17, 2025 | markets.businessinsider.comKorro Bio initiated with a Buy at ChardanApril 17, 2025 | markets.businessinsider.comChardan Capital Initiates Coverage of Korro Bio (KRRO) with Buy RecommendationApril 17, 2025 | msn.comKorro Bio, Inc. (NASDAQ:KRRO) Given Consensus Rating of "Buy" by BrokeragesKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) has received an average recommendation of "Buy" from the six brokerages that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The aApril 15, 2025 | marketbeat.comFranklin Resources Inc. Makes New $3.49 Million Investment in Korro Bio, Inc. (NASDAQ:KRRO)Franklin Resources Inc. acquired a new stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 91,757 shares of the company's stock, valued at approximately $3,493,000. FranApril 14, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Korro Bio (KRRO)April 11, 2025 | markets.businessinsider.comAlliancebernstein L.P. Makes New Investment in Korro Bio, Inc. (NASDAQ:KRRO)Alliancebernstein L.P. purchased a new position in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 705,794 shares of the company's stock, valued at approximatApril 8, 2025 | marketbeat.comKorro Bio appoints Loic Vincent as Chief Scientific OfficerApril 2, 2025 | markets.businessinsider.comKorro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific OfficerApril 1, 2025 | globenewswire.comKorro Bio: Promising Early Stage RNA Editing CompanyMarch 28, 2025 | seekingalpha.comResearch Analysts Set Expectations for Korro Bio Q1 EarningsKorro Bio, Inc. (NASDAQ:KRRO - Free Report) - HC Wainwright lowered their Q1 2025 earnings per share (EPS) estimates for Korro Bio in a research report issued on Thursday, March 20th. HC Wainwright analyst M. Kapoor now expects that the company will earn ($2.54) per share for the quarter, down frMarch 24, 2025 | marketbeat.comWhat is William Blair's Estimate for Korro Bio Q1 Earnings?Korro Bio, Inc. (NASDAQ:KRRO - Free Report) - Equities researchers at William Blair issued their Q1 2025 EPS estimates for shares of Korro Bio in a research report issued to clients and investors on Tuesday, March 18th. William Blair analyst M. Minter anticipates that the company will earn ($2.91March 22, 2025 | marketbeat.comKorro Bio's (KRRO) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $115.00 target price on shares of Korro Bio in a research report on Thursday.March 21, 2025 | marketbeat.comKorro Bio Reports 2024 Financial Results and ProgressMarch 21, 2025 | tipranks.comAnalysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX) and Korro Bio (KRRO)March 20, 2025 | markets.businessinsider.comRoyal Bank of Canada Issues Pessimistic Forecast for Korro Bio (NASDAQ:KRRO) Stock PriceRoyal Bank of Canada dropped their price objective on Korro Bio from $105.00 to $95.00 and set an "outperform" rating for the company in a report on Wednesday.March 20, 2025 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of "Buy" by AnalystsShares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have been assigned a consensus recommendation of "Buy" from the seven analysts that are covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the compMarch 20, 2025 | marketbeat.comKorro Bio, Inc.: Korro Reports Full Year 2024 Financial Results and Provides Business UpdatesMarch 19, 2025 | finanznachrichten.deIs Korro Bio (NASDAQ:KRRO) In A Good Position To Invest In Growth?March 19, 2025 | uk.finance.yahoo.comRBC Capital Remains a Buy on Korro Bio (KRRO)March 19, 2025 | markets.businessinsider.comKorro Bio price target lowered to $95 from $105 at RBC CapitalMarch 19, 2025 | markets.businessinsider.comKorro Bio (NASDAQ:KRRO) Posts Earnings Results, Beats Expectations By $0.15 EPSKorro Bio (NASDAQ:KRRO - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($2.26) EPS for the quarter, beating analysts' consensus estimates of ($2.41) by $0.15.March 19, 2025 | marketbeat.comWilliam Blair Remains a Buy on Korro Bio (KRRO)March 19, 2025 | markets.businessinsider.comKorro Bio reports FY24 EPS ($9.37), consensus ($9.73)March 18, 2025 | markets.businessinsider.comKorro Bio, Inc. Reports Progress in KRRO-110 Clinical Study for Alpha-1 Antitrypsin Deficiency and Financial Results for 2024March 18, 2025 | quiverquant.comKorro Reports Full Year 2024 Financial Results and Provides Business UpdatesMarch 18, 2025 | globenewswire.comKorro Bio (KRRO) Projected to Post Earnings on TuesdayKorro Bio (NASDAQ:KRRO) will be releasing earnings before the market opens on Tuesday, March 25, Financial Modeling Prep reports.March 18, 2025 | marketbeat.comKorro Bio's KRRO-110 Gets FDA Orphan Drug DesignationMarch 14, 2025 | marketwatch.comKorro Bio receives ODD from U.S. FDA for AATDMarch 14, 2025 | markets.businessinsider.comKorro Bio gets Orphan Drug Designation from FDA for its genetic disorder treatmentMarch 14, 2025 | msn.comKRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin DeficiencyMarch 14, 2025 | globenewswire.comKorro Bio’s treatment of alpha-1 antitrypsin deficiency gets orphan designationMarch 12, 2025 | markets.businessinsider.comKorro to Present at the TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comKorro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of "Buy" from AnalystsKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) has earned an average recommendation of "Buy" from the seven analysts that are covering the stock, MarketBeat reports. Six analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-monthFebruary 23, 2025 | marketbeat.comKorro Bio (NASDAQ:KRRO) Trading Down 2.9% - Time to Sell?Korro Bio (NASDAQ:KRRO) Stock Price Down 2.9% - Should You Sell?February 21, 2025 | marketbeat.comKorro Bio CFO takes medical leave, interim officers appointedFebruary 11, 2025 | msn.comKorro Bio, Inc. (NASDAQ:KRRO) Shares Bought by JPMorgan Chase & Co.JPMorgan Chase & Co. lifted its position in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 374.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,391 shares of the company's stock after purchasing an additional 9,78January 30, 2025 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of "Buy" from AnalystsShares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have been given a consensus recommendation of "Buy" by the seven research firms that are currently covering the company, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and one has given a strong buyJanuary 29, 2025 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Short Interest UpdateKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 653,900 shares, an increase of 50.1% from the December 15th total of 435,500 shares. Based on an average daily trading volume, of 140,800 shares, the days-to-cover ratio is currently 4.6 days. Approximately 11.7% of the shares of the stock are short sold.January 17, 2025 | marketbeat.com Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address KRRO Media Mentions By Week KRRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRRO News Sentiment▼1.060.72▲Average Medical News Sentiment KRRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRRO Articles This Week▼133▲KRRO Articles Average Week Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AnaptysBio News KalVista Pharmaceuticals News Arbutus Biopharma News Trevi Therapeutics News ChromaDex News Pharming Group News Organogenesis News CorMedix News Bicycle Therapeutics News Immatics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRRO) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KRRO Stock Free KRRO Stock Alerts